Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices. The Sports Medicine Joint Repair franchise offers surgeons a range of instruments, technologies and implants necessary to perform minimally invasive surgery of the joints, including the repair of soft tissue injuries and degenerative conditions of the knee, hip and shoulder. The AET franchise offers an array of minimally invasive surgery-enabling systems and devices. The Trauma & Extremities franchise supports healthcare professionals with solutions used by surgeons to stabilize severe fractures, correct bone deformities, treat arthritis and heal soft tissue complications.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Devices & Implants
- Sub-Industry: N/A
- Symbol: NYSE:SNN
- CUSIP: N/A
- Web: www.smith-nephew.com
Capitalization:- Market Cap: $15.74705 billion
- Outstanding Shares: 437,837,000
Average Prices:- 50 Day Moving Avg: $35.94
- 200 Day Moving Avg: $34.08
- 52 Week Range: $26.97 - $37.22
P/E:- Trailing P/E Ratio: 18.47
- Foreward P/E Ratio: 18.95
- P/E Growth: 0.00
Sales & Book Value:- Annual Revenue: $4.68 billion
- Price / Sales: 3.37
- Book Value: $9.59 per share
- Price / Book: 3.75
Dividend:- Annual Dividend: $0.61
- Dividend Yield: 1.7%
Profitability:Debt:- Debt-to-Equity Ratio: 0.38%
- Current Ratio: 2.18%
- Quick Ratio: 1.08%
Misc:- Average Volume: 394,659 shs.
- Beta: 0.75
- Short Ratio: 0.95
Frequently Asked Questions for Smith & Nephew SNATS (NYSE:SNN)
What is Smith & Nephew SNATS's stock symbol?
Smith & Nephew SNATS trades on the New York Stock Exchange (NYSE) under the ticker symbol "SNN."
How often does Smith & Nephew SNATS pay dividends? What is the dividend yield for Smith & Nephew SNATS?
Smith & Nephew SNATS declared a semiannual dividend on Monday, August 28th. Shareholders of record on Friday, October 6th will be paid a dividend of $0.246 per share on Wednesday, November 1st. This represents a yield of 1.37%. The ex-dividend date is Thursday, October 5th. View Smith & Nephew SNATS's Dividend History.
How were Smith & Nephew SNATS's earnings last quarter?
Smith & Nephew SNATS, Inc. (NYSE:SNN) posted its quarterly earnings results on Monday, November, 17th. The company reported $0.98 EPS for the quarter, beating analysts' consensus estimates of $0.39 by $0.59. View Smith & Nephew SNATS's Earnings History.
Who are some of Smith & Nephew SNATS's key competitors?
Some companies that are related to Smith & Nephew SNATS include Smith & Nephew plc (SN), Glaukos Corporation (GKOS), Endologix (ELGX), Cerus Corporation (CERS), RTI Surgical (RTIX), OBALON THERPTCS (OBLN), ConforMIS (CFMS), Second Sight Medical Products (EYES), Concepta PLC (CPT), Concepta PLC (FRI), Cyberonics (CYBX), HeartWare International (HTWR), St Jude Medical (STJ), Trivascular Technologies (TRIV) and Uroplasty (UPI).
Who are Smith & Nephew SNATS's key executives?
Smith & Nephew SNATS's management team includes the folowing people:
- Olivier Bohuon, Chief Executive Officer, Executive Director
- Graham Baker, Chief Financial Officer, Executive Director
- Rodrigo Bianchi, President, Asia Pacific and Emerging Markets
- Brad Cannon, President, Europe and Canada
- Vasant Padmanabhan Ph.D., President - Research & Development
- Cyrille Petit, Chief Corporate Development Officer, President - Global Business Services
- Matthew R. Stober, President - Global Operations
- Glenn S. Warner, President, US
- Elga Lohler, Chief Human Resource Officer
- John W. Campo, Chief Legal Officer
Who owns Smith & Nephew SNATS stock?
Smith & Nephew SNATS's stock is owned by many different of institutional and retail investors. Top institutional investors include Cambiar Investors LLC (1.21%), Arrowstreet Capital Limited Partnership (0.68%), Fisher Asset Management LLC (0.51%), Nuance Investments LLC (0.35%), Northern Trust Corp (0.14%) and Dalton Greiner Hartman Maher & Co. (0.11%). View Institutional Ownership Trends for Smith & Nephew SNATS.
Who sold Smith & Nephew SNATS stock? Who is selling Smith & Nephew SNATS stock?
Smith & Nephew SNATS's stock was sold by a variety of institutional investors in the last quarter, including Nuance Investments LLC, Sensato Investors LLC, JPMorgan Chase & Co., Ferguson Wellman Capital Management Inc., Thomas White International Ltd., Fisher Asset Management LLC, Boston Common Asset Management LLC and Cubist Systematic Strategies LLC. View Insider Buying and Selling for Smith & Nephew SNATS.
Who bought Smith & Nephew SNATS stock? Who is buying Smith & Nephew SNATS stock?
Smith & Nephew SNATS's stock was purchased by a variety of institutional investors in the last quarter, including Dalton Greiner Hartman Maher & Co., Arrowstreet Capital Limited Partnership, Goldman Sachs Group Inc., Blue Jay Capital Management LLC, Cambiar Investors LLC, US Bancorp DE, Manning & Napier Advisors LLC and Citadel Advisors LLC. View Insider Buying and Selling for Smith & Nephew SNATS.
How do I buy Smith & Nephew SNATS stock?
Shares of Smith & Nephew SNATS can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Smith & Nephew SNATS's stock price today?
One share of Smith & Nephew SNATS stock can currently be purchased for approximately $36.00.
MarketBeat Community Rating for Smith & Nephew SNATS (NYSE SNN)MarketBeat's community ratings are surveys of what our community members think about Smith & Nephew SNATS and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Smith & Nephew SNATS (NYSE:SNN) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 4 Hold Ratings, 2 Buy Ratings |
| Consensus Rating: | Hold (Score: 2.33) |
| Consensus Price Target: | N/A |
Analysts' Ratings History for Smith & Nephew SNATS (NYSE:SNN)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 2/27/2017 | Goldman Sachs Group, Inc. (The) | Downgrade | Buy -> Neutral | | N/A |  |
| 2/15/2017 | Berenberg Bank | Reiterated Rating | Hold | | N/A | |
| 1/19/2017 | HSBC Holdings plc | Initiated Coverage | Hold | | N/A | |
| 12/8/2016 | Morgan Stanley | Upgrade | Equal Weight -> Overweight | | N/A | |
| 11/8/2016 | Bank of America Corporation | Reiterated Rating | Buy | | N/A | |
| 11/7/2016 | Deutsche Bank AG | Reiterated Rating | Hold | | N/A | |
| 8/10/2016 | Beaufort Securities | Reiterated Rating | Hold | | N/A | |
| 8/10/2016 | Barclays PLC | Downgrade | Overweight -> Equal Weight | | N/A | |
| 5/9/2016 | Jefferies Group LLC | Upgrade | Hold -> Buy | | N/A | |
| 3/17/2016 | Nomura | Initiated Coverage | Neutral | | N/A | |
| 2/26/2016 | Cantor Fitzgerald | Initiated Coverage | Hold | | N/A | |
| 11/4/2015 | Sterne Agee CRT | Initiated Coverage | Neutral | | N/A | |
| 11/2/2015 | Sanford C. Bernstein | Boost Price Target | | $39.50 -> $41.00 | N/A | |
| 11/1/2015 | J P Morgan Chase & Co | Reiterated Rating | Neutral | | N/A | |
| 10/30/2015 | Brean Capital | Reiterated Rating | Hold | | N/A | |
| 10/30/2015 | Charles Stanley | Downgrade | Reduce | | N/A | |
| 10/29/2015 | Canaccord Genuity | Lower Price Target | Buy | $39.00 -> $33.00 | N/A | |
(Data available from 9/22/2015 forward)
Earnings History for Smith & Nephew SNATS (NYSE:SNN)Earnings History by Quarter for Smith & Nephew SNATS (NYSE SNN)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 2/5/2015 | Q4 | $0.51 | $0.51 | $1.29 billion | $1.25 billion | View | N/A | |
| 11/17/2014 | | $0.39 | $0.98 | | | View | N/A | |
| 10/29/2014 | | $0.38 | $0.39 | $1.15 billion | $1.15 billion | View | N/A | |
| 8/1/2014 | | $0.94 | $1.02 | $1.13 billion | $1.15 billion | View | N/A | |
| 5/1/2014 | | $0.93 | $0.89 | $1.09 billion | $1.07 billion | View | N/A | |
| 2/6/2014 | Q4 | $1.13 | $1.16 | $1.17 billion | $1.18 billion | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Smith & Nephew SNATS (NYSE:SNN)2017 EPS Consensus Estimate: $1.72
2018 EPS Consensus Estimate: $1.88
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 1 | $0.00 | $0.00 | $0.00 |
| Q2 2017 | 1 | $0.77 | $0.77 | $0.77 |
| Q3 2017 | 1 | $0.00 | $0.00 | $0.00 |
| Q4 2017 | 1 | $0.95 | $0.95 | $0.95 |
| Q1 2018 | 1 | $0.00 | $0.00 | $0.00 |
| Q2 2018 | 1 | $0.87 | $0.87 | $0.87 |
| Q3 2018 | 1 | $0.00 | $0.00 | $0.00 |
| Q4 2018 | 1 | $1.01 | $1.01 | $1.01 |
(Data provided by Zacks Investment Research)
Current Dividend Information for Smith & Nephew SNATS (NYSE:SNN)| Next Dividend: | 11/1/2017 |
| Annual Dividend: | $0.61 |
| Dividend Yield: | 1.69% |
| Dividend Growth: | -21.60% (3 Year Average) |
| Payout Ratio: | 33.89% (Based on This Year's Estimates)
32.11% (Based on Next Year's Estimates)
|
| Track Record: | 4 Years of Consecutive Dividend Growth |
Dividend History by Quarter for Smith & Nephew SNATS (NYSE SNN)| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 8/28/2017 | semiannual | $0.25 | 1.37% | 10/5/2017 | 10/6/2017 | 11/1/2017 |
| 2/28/2017 | semiannual | $0.37 | 2.42% | 3/29/2017 | 3/31/2017 | 5/10/2017 |
| 9/1/2016 | | $0.24 | | 10/5/2016 | 10/7/2016 | 10/25/2016 |
| 2/8/2016 | | $0.37 | | 4/20/2016 | 4/22/2016 | 5/11/2016 |
| 4/9/2015 | semiannual | $0.37 | 2.13% | 4/15/2015 | 4/17/2015 | 5/6/2015 |
| 9/9/2014 | semiannual | $0.55 | 1.28% | 10/22/2014 | 10/24/2014 | 11/12/2014 |
| 2/20/2014 | semiannual | $0.85 | 2.12% | 4/17/2014 | 4/22/2014 | 5/7/2014 |
| 8/28/2013 | special | $0.52 | 2.73% | 10/9/2013 | 10/11/2013 | 10/29/2013 |
| 3/11/2013 | semiannual | $0.81 | 2.97% | 4/17/2013 | 4/19/2013 | 5/8/2013 |
(Data available from 1/1/2013 forward)
Insider Trading History for Smith & Nephew SNATS (NYSE:SNN)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Smith & Nephew SNATS (NYSE:SNN)
Latest Headlines for Smith & Nephew SNATS (NYSE:SNN)
| Source: |
|
| Date | Headline |
|---|
 | Smith & Nephew SNATS, Inc. (SNN) Upgraded at Zacks Investment Research
www.americanbankingnews.com - September 20 at 9:46 AM |
| Critical Review: Smith & Nephew SNATS (SNN) and HeartWare International (HTWR)
www.americanbankingnews.com - September 19 at 6:10 PM |
| Smith & Nephew SNATS, Inc. (SNN) Cut to Hold at Zacks Investment Research
www.americanbankingnews.com - September 19 at 7:12 AM |
| Critical Analysis: Smith & Nephew SNATS (SNN) & HeartWare International (HTWR)
www.americanbankingnews.com - September 18 at 2:30 PM |
 | ETFs with exposure to Smith & Nephew Plc : September 14, 2017
finance.yahoo.com - September 14 at 10:19 AM |
| Head-To-Head Comparison: Glaukos Corporation (GKOS) vs. Smith & Nephew SNATS (SNN)
www.americanbankingnews.com - September 3 at 10:08 AM |
| Smith & Nephew SNATS, Inc. (SNN) Receives Consensus Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - September 2 at 12:58 PM |
| Contrasting St Jude Medical (STJ) & Smith & Nephew SNATS (SNN)
www.americanbankingnews.com - September 2 at 12:20 PM |
| Contrasting Smith & Nephew SNATS (SNN) and Second Sight Medical Products (EYES)
www.americanbankingnews.com - September 1 at 12:20 PM |
| Smith & Nephew SNATS, Inc. (SNN) Plans Semiannual Dividend of $0.25
www.americanbankingnews.com - August 28 at 6:26 PM |
| ETFs with exposure to Smith & Nephew Plc : August 25, 2017
finance.yahoo.com - August 25 at 9:23 PM |
| ETFs with exposure to Smith & Nephew Plc : August 14, 2017
finance.yahoo.com - August 15 at 7:07 AM |
| Reviewing Trivascular Technologies (TRIV) & Smith & Nephew SNATS (NYSE:SNN)
www.americanbankingnews.com - August 13 at 4:18 PM |
| Smith & Nephew SNATS (NYSE:SNN) vs. ConforMIS (CFMS) Head to Head Contrast
www.americanbankingnews.com - August 9 at 10:26 AM |
| Smith & Nephew SNATS, Inc. (SNN) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - August 8 at 12:44 PM |
| Smith & Nephew SNATS (NYSE:SNN) vs. Cerus (CERS) Head to Head Comparison
www.americanbankingnews.com - August 8 at 8:30 AM |
| FY2017 EPS Estimates for Smith & Nephew SNATS, Inc. Boosted by Analyst (SNN)
www.americanbankingnews.com - August 2 at 10:10 AM |
| Smith & Nephew Plc :SNN-US: Earnings Analysis: For the six months ended June 30, 2017 : July 31, 2017
finance.yahoo.com - August 1 at 6:28 AM |
| Critical Comparison: Smith & Nephew SNATS (SNN) & Cyberonics (CYBX)
www.americanbankingnews.com - July 19 at 12:15 AM |
| Smith & Nephew SNATS, Inc. (NYSE:SNN) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - July 14 at 12:56 PM |
| Head to Head Contrast: Obalon Therapeutics (OBLN) & Smith & Nephew SNATS (NYSE:SNN)
www.americanbankingnews.com - July 14 at 12:08 AM |
| Northcoast Research Research Analysts Lift Earnings Estimates for Smith & Nephew SNATS, Inc. (NYSE:SNN)
www.americanbankingnews.com - July 10 at 7:37 AM |
| Zacks Investment Research Downgrades Smith & Nephew SNATS, Inc. (SNN) to Hold
www.americanbankingnews.com - June 27 at 9:52 AM |
| Smith & Nephew SNATS, Inc. (SNN) Upgraded at BidaskClub
www.americanbankingnews.com - June 23 at 5:54 PM |
| Smith & Nephew SNATS, Inc. (SNN) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - June 19 at 12:49 PM |
| Training Memphis' next generation of agtech and biotech workers
finance.yahoo.com - June 17 at 6:15 AM |
| Smith & Nephew SNATS, Inc. (SNN) Cut to "Buy" at BidaskClub
www.americanbankingnews.com - June 13 at 8:32 PM |
| Smith & Nephew plc (SNN) Upgraded at Zacks Investment Research
www.americanbankingnews.com - June 7 at 9:08 PM |
| Smith & Nephew plc (SNN) Sees Large Decline in Short Interest
www.americanbankingnews.com - May 25 at 7:28 PM |
| Smith & Nephew plc (SNN) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - May 23 at 12:52 PM |
| Smith & Nephew plc (SNN) Sees Significant Drop in Short Interest
www.americanbankingnews.com - May 17 at 7:14 AM |
| Study results demonstrate 74% reduction in surgical site infections with use of PICO™ Single use Negative Pressure Wound Therapy system
finance.yahoo.com - May 16 at 9:05 AM |
| Q2 2017 EPS Estimates for Smith & Nephew plc (SNN) Cut by Analyst
www.americanbankingnews.com - May 9 at 7:20 AM |
 | Smith & Nephew Reports 3% Underlying Revenue Growth In Q1 - Quick Facts
www.rttnews.com - May 6 at 1:18 AM |
| Collagenase SANTYL® Ointment advances pressure ulcers through the healing process faster, new study suggests
finance.yahoo.com - May 4 at 10:59 AM |
| Smith & Nephew plc (SNN) Earns Coverage Optimism Rating of 0.03
www.americanbankingnews.com - May 2 at 9:12 PM |
| Smith & Nephew plc (SNN) Given Daily Media Sentiment Rating of 0.05
www.americanbankingnews.com - April 29 at 7:59 PM |
| Smith & Nephew plc (SNN) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - April 28 at 2:20 PM |
| ETFs with exposure to Smith & Nephew Plc : April 27, 2017
finance.yahoo.com - April 27 at 8:25 PM |
| Smith & Nephew plc (SNN) Receives Media Impact Rating of 0.17
www.americanbankingnews.com - April 26 at 8:00 PM |
| Smith & Nephew plc (SNN) Earns Media Impact Rating of 0.56
www.americanbankingnews.com - April 20 at 1:08 PM |
| Smith & Nephew plc (SNN) Earning Somewhat Negative Press Coverage, Report Shows
www.americanbankingnews.com - April 17 at 5:03 PM |
| Smith & Nephew plc (SNN) Earns Daily News Impact Rating of 0.46
www.americanbankingnews.com - April 14 at 11:42 AM |
| Smith & Nephew plc (SNN) Upgraded by Zacks Investment Research to Hold
www.americanbankingnews.com - April 12 at 11:29 PM |
| Smith & Nephew Plc : SNN-US: Dividend Analysis : March 31st, 2017 (record date) : By the numbers : April 11, 2017
finance.yahoo.com - April 11 at 7:39 PM |
| ETFs with exposure to Smith & Nephew Plc : April 7, 2017
finance.yahoo.com - April 7 at 9:38 PM |
| Smith & Nephew plc (SNN) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - April 6 at 4:45 PM |
| Jefferies Group Comments on Smith & Nephew plc's FY2017 Earnings (SNN)
www.americanbankingnews.com - March 31 at 12:47 PM |
| Smith & Nephew plc (SNN) to Post FY2018 Earnings of $1.90 Per Share, Jefferies Group Forecasts
www.americanbankingnews.com - March 30 at 12:17 PM |
 | Smith & Nephew plc goes ex-dividend tomorrow
seekingalpha.com - March 28 at 9:00 AM |
Smith & Nephew SNATS (SNN) Chart for Friday, September, 22, 2017
